VHCP Management III, LLC
New York, NY · CIK 1738053 · 13F filing filed 2020-02-13
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyNew York, NY
$503.6m
reported value
18positions
90.4%in top 10
—no comparable previous quarter
Holdings, Q4 2019
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| AXSOME THERAPEUTICS INC AXSM | $160.0m31.77% | — |
| CONSTELLATION PHARMCETICLS I CNST | $118.5m23.54% | — |
| MILESTONE PHARMACEUTICALS IN MIST | $33.1m6.57% | — |
| RELMADA THERAPEUTICS INC RLMD | $29.9m5.95% | — |
| 89BIO INC ETNB | $25.2m5.00% | — |
| 10X GENOMICS INC TXG | $22.9m4.54% | — |
| FORTY SEVEN INC FTSV | $20.3m4.04% | — |
| INTRA-CELLULAR THERAPIES INC ITCI | $19.7m3.92% | — |
| IVERIC BIO INC OPHT | $14.6m2.90% | — |
| KALVISTA PHARMACEUTICALS INC KALV | $11.0m2.19% | — |
| ADVERUM BIOTECHNOLOGIES INC COM | $10.9m2.16% | — |
| MARINUS PHARMACEUTICALS INC MRNS | $10.8m2.15% | — |
| MERSANA THERAPEUTICS INC COM | $8.9m1.78% | — |
| MYOVANT SCIENCES LTD MYOV | $7.1m1.40% | — |
| NEXTCURE INC COM | $6.7m1.34% | — |
| OBSEVA SA COM | $3.1m0.61% | — |
| PROTAGONIST THERAPEUTICS INC PTGX | $571.0k0.11% | — |
| BELLEROPHON THERAPEUTICS INC BLPH | $134.0k0.03% | — |